170816 ⎘
Detection or diagnosis of diseases Pulmonary diseases
Sub-classes:ANAKINRA FOR THE TREATMENT OF POST ACUTE COVID SYNDROME
#2SIGNATURE OF TL1A (TNFSF15) SIGNALING PATHWAY
#3PULMONARY ARTERIAL HYPERTENSION PATIENT SELECTION METHOD AND BIOMARKER
#4METHODS RELATING TO IMPAIRED RESPIRATORY HEALTH THERAPEUTICS
#5METHODS FOR NONINVASIVE MONITORING OF BRONCHOPULMONARY DYSPLASIA
#6EXHALED BIOMARKER FOR DIAGNOSIS AND PROGNOSIS OF PATIENT WITH IDIOPATHIC PULMONARY FIBROSIS
#7NOVEL BIOMARKER VISTA FOR DIAGNOSIS AND PROGNOSIS OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
#8METHOD FOR DIAGNOSING ACUTE EXACERBATION OF BRONCHIECTASIS AND KIT THEREFOR
#9USE OF SET7/9 FOR DIAGNOSING AND TREATING ENDMT-RELATED DISEASE
#10RECOMBINANT ANTIBODY OF ANTI-HUMAN CARDIAC TROPONIN I
#11COMPOSITIONS AND METHODS FOR DETECTION AND TREATMENT OF CORONAVIRUS INFECTION
#12Anastellin Biomarker
#13Anastellin Biomarker
#14BIOMARKERS FOR THE TREATMENT OF INTERSTITIAL LUNG DISEASE
#15COLLAGEN TYPE VII ALPHA 1 ASSAY
#16DIAGNOSTIC PLATFORM FOR TESTING EXHALED BREATH CONDENSATE AND UNIVERSAL BIOSENSOR
#17METHODS FOR DETERMINING RESPIRATORY INFECTION RISK
#18DIAGNOSIS OF TUBERCULOSIS AND OTHER DISEASES USING EXHALED BREATH
#19COMPOSITIONS AND TREATMENTS FOR CORONAVIRUS INFECTIONS
#20DIAGNOSIS OF ACUTE AND CHRONIC LUNG DISEASES BY QUANTIFYING SPINK1 LEVEL
#21METHOD OF SIMULTANEOUSLY DIAGNOSING ACTIVE TUBERCULOSIS AND LATENT TUBERCULOSIS INFECTION USING HUMAN WHOLE BLOOD SAMPLE-DERIVED BIOMARKER
#22METHODS AND COMPOSITIONS BASED ON LONGITUDINAL STUDIES
#23METHODS FOR PREDICTING RISK OF INTERSTITIAL PNEUMONIA
#24AUTOANTIBODIES FOR USE IN IDENTIFYING DISEASE
#25METHODS AND COMPOSITIONS FOR TREATING PULMONARY ALVEOLAR PROTEINOSIS RELATED TO MARS MUTATIONS
#26DISPLAY APPARATUS AND SENSING METHOD USING THE SAME
#27EVALUATION OF PATIENTS WITH CYSTIC FIBROSIS USING SWEAT
#28Sample Collection Device and Method
#29TISSUE TESTER
#30DIAGNOSIS OF RESPIRATORY DISEASES BY CAPTURING AEROSOLIZED BIOMATERIAL PARTICLES USING PACKED BED SYSTEMS AND METHODS
#31Use of Biomarkers in the Treatment of Fibrotic Conditions with a PDE4B-inhibitor
#32CELL CULTURE GROWTH APPARATUS AND METHOD OF UNDERSIDE ATTACHMENT TO A SURFACE USING CELL SEEDING
#33SERUM PROTEIN BIOMARKER PANEL FOR IDIOPATHIC PULMONARY FIBROSIS
#34USE OF MALIC ENZYME 2 IN PREPARATION OF DIAGNOSTIC REAGENT OR MEDICAMENT FOR SILICOSIS OR PULMONARY FIBROSIS-RELATED DISEASE
#35COMPOSITIONS AND METHODS FOR THE TREATMENT OF BRONCHIOLITIS OBLITERANS
#36METHODS AND COMPOSITIONS FOR RISK PREDICTION, DIAGNOSIS, PROGNOSIS, AND TREATMENT OF PULMONARY DISORDERS
#37METHODS FOR TREATING EXACERBATIONS OF INFLAMMATORY RESPIRATORY DISEASES
#38CIRCULATING TUMOR CELL DIAGNOSTICS FOR LUNG CANCER
#39Apparatus for diagnosing lung cancer based on exhaled breath and method for diagnosing same
#40Diagnostic Method and Compounds for the Treatment of Infections Caused by a Pathogen
#41Treatment of severe community acquired pneumonia
#42Biomarkers for identifying e-cigarette, or vaping, product use-associated lung injury
#43TRIAGING METHOD USING CELL FREE NUCLEOSOME LEVELS
#44METHODS FOR USING PROTEIN BIOMARKERS IN IDIOPATHIC PULMONARY FIBROSIS
#45PRO-ADRENOMEDULLIN FOR PROGNOSING DISEASE PROGRESSION IN SEVERE ACUTE RESPIRATORY SYNDROME (SARS)
#46DETECTION AND TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
#47Methods and Apparatuses for Early Diagnosis of Lung Infection Acuity
#48A Point of Care Device, Method and Kit Involving Club Cell Protein 16 as a Marker for Silicosis
#49The Kinase NEK10 and Its Use in Treating and Diagnosing Bronchiectasis and Other Respiratory Disorders
#50METHOD FOR ASSAYING LOWER RESPIRATORY TRACT INFECTION OR INFLAMMATION
#51Method of identifying and treating premature infants at risk for BPD
#52Pulmonary hypertension biomarker
#53Signature of TL1A (TNFSF15) signaling pathway
#54CIRCULATING BIOMARKERS OF PRECLINICAL PULMONARY FIBROSIS
#55CAPTURING TRUNCATED PROTEOFORMS IN EXHALED BREATH FOR DIAGNOSIS AND TREATMENT OF DISEASES
#56METHODS FOR DETERMINING THE SEVERITY AND PROGNOSIS OF RSV INFECTION
#57MUCIN ISOFORMS IN DISEASES CHARACTERIZED BY BARRIER DYSFUNCTION
#58COMPOSITIONS AND METHODS FOR PREDICTING LUNG FUNCTION DECLINE IN IDIOPATHIC PULMONARY FIBROSIS
#59DRUG TARGET OF IDIOPATHIC PULMONARY FIBROSIS
#60ANTIGEN BINDING PROTEINS AND ASSAYS
#61Method for acquiring information on respiratory infection
#62Methods and systems for detecting usual interstitial pneumonia
#63Modulators of airway basal cells for the treatment or prevention of lung diseases
#64Compositions and methods for detection and treatment of coronavirus infection
#65TISSUE TESTER
#66Methods of treating chronic disorders with complement inhibitors
#67COMPOSITIONS AND METHODS FOR DETERMINING CORONAVIRUS NEUTRALIZATION TITERS
#68Diagnosis of tuberculosis and other diseases using exhaled breath
#69Methods for diagnosing and/or treating acute or chronic liver, kidney or lung disease
#70METHOD OF SIMULTANEOUSLY DIAGNOSING ACTIVE TUBERCULOSIS AND LATENT TUBERCULOSIS INFECTION USING HUMAN WHOLE BLOOD SAMPLE-DERIVED BIOMARKER
#71METHOD FOR PREDICTING EFFECT OF IMMUNE CHECKPOINT INHIBITOR
#72Recombinant antibody against human cardiac troponin I
#73METHOD FOR OBTAINING INFORMATION ON RISK OF REDUCED RESPIRATORY FUNCTION IN PATIENT WITH INTERSTITIAL PNEUMONIA
#74SARS-CoV-2 surrogate virus neutralization assay test kit
#75COLLAGEN TYPE VII ALPHA 1 ASSAY
#76APPARATUS AND METHODS FOR DISEASE DETECTION AND TREATMENT
#77PREDICTING MORTALITY AND DETECTING SEVERE DISEASE
#78Methods and compositions for risk prediction, diagnosis, prognosis, and treatment of pulmonary disorders
#79Methods and reagents for diagnosis of SARS-CoV-2 infection
#80METHOD
#81Treatment of severe community acquired pneumonia
#82TMEM16A Modulation for Diagnostic or Therapeutic Use in Pulmonary Hypertension (PH)
#83CIRCULATING TUMOR CELL DIAGNOSTICS FOR LUNG CANCER
#84Monoclonal antibodies specifically for the antigen P of the human respiratory syncytial virus, produced and secreted by the cells hybridomas, useful for detection and diagnostic of the infection caused by RSV
#85Stem cell-based lung-on-chip models
#86Methods for Increasing the Selective Efficacy of Gene Therapy Using CAR Peptide and Heparan-Sulfate Mediated Macropinocytosis
#87Methods for predicting risk of interstitial pneumonia
#88BIOMARKERS FOR DIAGNOSIS OF LUNG DISEASES AND METHODS OF USE THEREOF
#89Pulse Stable Tracer Methods for Detection of Short-Chain Fatty Acids
#90Methods of detecting and treating pulmonary hypertension
#91Fetal lung maturity test
#92Modifiers of CFTR-directed therapy
#93Detection of cleavage activity of an enzyme
#94Method for measuring a biomarker in a biological sample of an IPAF patient
#95Methods of treating chronic disorders with complement inhibitors
#96BIOMARKERS FOR SYSTEMS, METHODS, AND DEVICES FOR DETECTING AND IDENTIFYING SUBSTANCES IN A SUBJECT'S BREATH, AND DIAGNOSING AND TREATING HEALTH CONDITIONS
#97COMPOSITIONS AND METHODS FOR DETECTING AND TREATING PATHOLOGICAL FIBROBLAST CELLS
#98Methods for predicting the risk of developing pulmonary colonization/infection by
#99Treatment of severe community acquired pneumonia
#100DIAGNOSTIC MARKERS FOR BOVINE TUBERCULOSIS AND USES THEREOF
#101Devices and methods related to airway inflammation
#102Monitoring inflammation status
#103Signature of TL1A (TNFSF15) signaling pathway
#104Method of identifying and treating premature infants at risk for BPD
#105Method of diagnosing tuberculosis
#106Therapeutic agent for a lung disease and/or method for screening for the same
#107Compositions and methods for detecting and treating pathological fibroblast cells
#108Lung protease nanosensors and uses thereof
#109On-surface mass tagging
#110Therapeutic agents
#111PULMONARY HYPERTENSION BIOMARKER
#112ALX receptor ligands define a biochemical endotype for inflammation-based diseases
#113Proteomics based diagnostic detection method for chronic sinusitis
#114METHOD FOR DIAGNOSING COMPLICATED PARAPNEUMONIC EFFUSION
#115Inhalable nanosensors with volatile reporters and uses thereof
#116Method of predicting progression of idiopathic pulmonary fibrosis and monitoring of therapeutic efficacy
#117System and method for differential diagnosis of diseases
#118Method for detecting active tuberculosis
#119METHODS OF TREATING CHRONIC DISORDERS WITH COMPLEMENT INHIBITORS
#120HISTONES AND/OR PROADM AS MARKERS INDICATING ORGAN DYSFUNCTION
#121Targeting fibroblast invasion for pulmonary fibrosis
#122METHOD AND APPARATUS FOR THE DIAGNOSIS OF PNEUMONIA USING EXHALED BREATH METABOLOMICS
#123Methods and kits for diagnosing postoperative pulmonary infections in patients who underwent surgery
#124Biomarker for the diagnosis of pulmonary hypertension (PH)
#125TISSUE TESTER
#126Method of testing for pulmonary hypertension
#127TREATMENT OF SEVERE COMMUNITY ACQUIRED PNEUMONIA
#128MEANS AND METHODS FOR DIFFERENTIATING BETWEEN HEART FAILURE AND PULMONARY DISEASE IN A SUBJECT
#129Sensor technology for diagnosing tuberculosis
#130METHODS OF PROGNOSING, DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS
#131Diagnostic assays and methods of treating pneumonia, sepsis and systemic inflammatory response syndrome
#132Predicting mortality and detecting severe disease
#133Methods and compositions for risk prediction, diagnosis, prognosis, and treatment of pulmonary disorders
#134Methods to identify antituberculosis compounds
#135USE OF SERELAXIN TO REDUCE GDF-15
#136Proteomics based diagnostic detection method for chronic sinusitis
#137Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy
#138Use of IL-3, IL-33 and IL-12p40 as markers for characterization of respiratory infections by respiratory syncytial virus
#139Monoclonal antibodies specifically for the antigen P of the human respiratory syncytial virus, produced and secreted by the cells hybridomas, useful for detection and diagnostic of the infection caused by RSV
#140CORE ELEMENTS FOR POINT OF CARE DIAGNOSIS OF TUBERCULOSIS
#141Method for assaying lower respiratory tract infection or inflammation
#142MODIFIERS OF CFTR-DIRECTED THERAPY
#143Therapeutic Agents
#144Polypeptide having chemokine activity and uses thereof
#145INHIBITORY IMMUNOGLOBULINS
#146Methods of using antibodies to determine periostin levels in a sample
#147Volatile organic compounds as diagnostic breath markers for pulmonary oxygen toxicity
#148NOVEL ASSAY TO DETECT HUMAN PERIOSTIN
#1492,7-disubstituted cephalosporin derivatives as β-lactamase substrates and methods for their use for the diagnosis of tuberculosis
#150METHOD OF IDENTIFYING PROTEINS IN HUMAN SERUM INDICATIVE OF PATHOLOGIES OF HUMAN LUNG TISSUES
#151Risk Factors of Cigarette Smoke-Induced Spriometric Phenotypes
#152Attractin and lumican biomarkers in idiopathic pneumonia syndrome
#153Method of diagnosing and treating asphyxia
#154ADAM12 inhibitors and their use against inflammation-induced fibrosis
#155Devices and methods for measuring the properties of macromolecules
#156Compositions and methods for inhibiting fibrosis
#157Methods for Increasing the Selective Efficacy of Gene Therapy Using CAR Peptide and Heparan Sulfate Mediated Macropinocytosis
#158Analytical Methods and Arrays for Use in the Same
#159Circulating pulmonary hypertension biomarker
#160Method for treating and diagnosing disease using inhibitors of goodpasture antigen binding protein
#161Use of fibroblast growth factor 2
#162Methods of identifying and treating premature infants at risk for BPD
#163Proteomics based diagnostic detection method for chronic sinusitis
#164Predicting mortality and detecting severe disease
#165GrB-EHinhibitory peptides
#166Methods for the diagnosis and treatment of pulmonary fibrosis in subjects with hermansky pudlak syndrome
#167Monitoring Inflammation Status
#168USE OF SERELAXIN TO REDUCE GDF-15
#169METHOD OF TESTING FOR PULMONARY HYPERTENSION
#170PULMONARY HYPERTENSION BIOMARKER
#171INHALATION OF NITRIC OXIDE FOR TREATING RESPIRATORY DISEASES
#172Blockade of CCL18 signaling via CCR6 as a therapeutic option in treating interstitial lung disease
#173ANTIBODY CAPABLE OF BINDING TO SPECIFIC REGION OF PERIOSTIN, AND METHOD FOR MEASURING PERIOSTIN USING SAME
#174Monoclonal antibodies which bind human periostin
#175LTBP2 AS A BIOMARKER FOR RENAL DYSFUNCTION
#176Detection of cleavage activity of an enzyme
#177Signature of TL1A (TNFSF15) signaling pathway
#178Devices and methods related to airway inflammation
#179Compositions and methods
#180Methods of Diagnosis and Treatment for Pulmonary Arterial Hypertension
#181Method of diagnosing tuberculosis
#182Diagnosis of respiratory tract infectious disease using urine specimens
#183Diagnosis of respiratory tract infectious disease using blood specimens
#184DIAGNOSIS AND RISK STRATIFICATION USING NT-proET-1
#185Methods and system for use in neonatal diagnostics
#186Methods for predicting risk of interstitial pneumonia
#187Methods for increasing the selective efficacy of gene therapy using CAR peptide and heparan-sulfate mediated macropinocytosis
#188USE OF SEPRASE FOR DIFFERENTIAL DIAGNOSIS OF ACUTE DYSPNEA
#189TREATMENT AND PROGNOSIS OF LYMPHANGIOLEIOMYOMATOSIS
#190Method and apparatus for non-invasive detection of conditions such as lung cancer
#191MCAM as a biomarker for fluid homeostasis
#192SUPPRESSION OF LEPTIN ACTION FOR TREATMENT OF PULMONARY INFECTIONS
#193Sensor technology for diagnosing tuberculosis
#194Methods for diagnosing pulmonary hypertension
#195DIAGNOSIS AND TREATMENT OF ASPIRIN-EXACERBATED RESPIRATORY DISEASE (AERD)
#196CYSTATIN C AND GALECTIN-3 AS BIOMARKERS FOR PULMONARY ARTERIAL HYPERTENSION
#197Integrated quantification method for protein measurements in clinical proteomics
#198Screening methods for transfusion related acute lung injury (TRALI)
#199Human autoantibodies specific for PAD3 which are cross-reactive with PAD4 and their use in the diagnosis and treatment of rheumatoid arthritis and related diseases
#200CIRCULATING TUMOR CELL DIAGNOSTICS FOR LUNG CANCER
#201METHOD AND SYSTEM FOR IDENTIFYING LEAKY LUNG EPITHELIAL BARRIER
#202System and Method for Analyzing Samples Labeled with 5, 10, 15, 20 Tetrakis (4-Carboxyphenyl) Porphine (TCPP)
#203Metabolomics in pneumonia and sepsis
#204Liposomal composition comprising a sterol-modified lipid and a purified mycobacterial lipid cell wall component and its use in the diagnosis of tuberculosis
#205PGLYRP2 biomarker in idiopathic pneumonia syndrome
#206Method for diagnosis of pulmonary involvement in systemic sclerosis
#207BIOMARKERS OF PULMONARY HYPERTENSION
#208PCSK9 Function Assay
#209Diagnosis and risk stratification by determining the marker CT-proADM
#210PULMONARY HYPERTENSION
#211ADAM12 inhibitors and their use against inflammation-induced fibrosis
#212Methods of treating chronic disorders with complement inhibitors
#213Marker Panels For Idiopathic Pulmonary Fibrosis Diagnosis And Evaluation
#214METHODS AND PHARMACEUTICAL COMPOSITIONS FOR REDUCING AIRWAY HYPERRESPONSE
#215Antibody capable of binding to specific region of periostin, and method of measuring periostin using the same
#216Proteomic IPF markers
#217Compositions and methods for augmenting permeability barriers
#218Diagnosis of respiratory tract infectious disease using blood specimens
#219Diagnosis of respiratory tract infectious diseases using urine specimens
#220Compositions and methods of using micro RNAs
#221Diagnostic assays and methods of treating pneumonia, sepsis and systemic inflammatory response syndrome
#222Artificial tissue constructs comprising alveolar cells and methods for using the same
#223Human autoantibodies specific for PAD3 which are cross-reactive with PAD4 and their use in the diagnosis and treatment of rheumatoid arthritis and related diseases
#224Methods of screening compounds for the fibril formation of Aβ peptides based on a decreased trimer/monomer ratio of a chaperone protein
#225Methods and kits for predicting the risk of respiratory failure, renal failure or thrombopenia in a septic patient by measuring endocan levels in blood
#226Cell division marker
#227Biomarkers for pneumonia and acute decompensated heart failure
#228Method for screening for a therapeutic agent for idiopathic interstitial pneumonia
#229Biomarkers associated with autoimmune diseases of the lung
#230COMPOSITION FOR THE DIAGNOSIS OF OVARIAN CANCER OR PNEUMONIA COMPRISING THIOREDOXIN 1 AS ACTIVE INGREDIENT AND USE THEREOF
#231Biomarkers of lung function
#232Metabolomics-based biomarkers for lung function
#233METHODS AND COMPOSITIONS RELATING TO MULTICILIATE CELL DIFFERENTIATION
#234LTBP2 AS A BIOMARKER FOR RENAL DYSFUNCTION
#235METHODS AND COMPOSITIONS FOR DIAGNOSING PULMONARY FIBROSIS SUBTYPES AND ASSESSING THE RISK OF PRIMARY GRAFT DYSFUNCTION AFTER LUNG TRANSPLANTATION
#236Peripheral Blood Biomarkers for Idiopathic Interstitial Pneumonia and Methods of Use
#237Methods of diagnosing and treating pulmonary diseases or disorders
#238METHODS FOR DIAGNOSIS AND PROGNOSIS OF PULMONARY HYPERTENSION
#239BIOMARKERS PREDICTIVE OF PROGRESSION OF FIBROSIS
#240MCAM as a biomarker for fluid homeostasis
#241BIOMARKERS FOR PROGNOSES OF PULMONARY DISEASES
#242FIBROSIS INHIBITOR
#243ADAM12 Inhibitors and Their Use Against Inflammation-Induced Fibrosis
#244BIOMARKER FOR DIAGNOSIS, PREDICTION AND/OR PROGNOSIS OF ACUTE HEART FAILURE AND USES THEREOF
#245Methods for treating and diagnosing disease
#246Method for diagnosing and treating emphysema
#247Method, device, or system using lung sensor for detecting a physiological condition in a vertebrate subject
#248Method of diagnosing and treating asphyxia
#249Semi-Invasive Method for Characterizing Lung Injury
#250METHODS OF ASSESSING AND TREATING PULMONARY DISEASE
#251Methods for treating and diagnosing fibrotic and fibroproliferative diseases
#252Detection of bacterial infections in subjects suffering from dyspnea
#253Method for identifying idiopathic pneumonia progression by measuring the level of mannose-binding protein C
#254Screening methods for transfusion related acute lung injury
#255Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof
#256Methods of identifying a subject as having heart failure
#257Marker panels for idiopathic pulmonary fibrosis diagnosis and evaluation
#258METHODS AND KITS FOR DETERMINING THE PROGNOSIS OF PULMONARY SARCOIDOSIS
#259Use of VEGF-D in the diagnosis of lymphangioleiomyomatosis (LAM) disease
#260METHODS FOR DIAGNOSIS AND PROGNOSIS OF PULMONARY HYPERTENSION
#261Anti-αβantibodies and uses thereof
#262Ets-2 Biomarkers for Fibrotic Diseases and Uses Thereof
#263Detection and treatment of non-dermal fibrosis
#264COMBINED NATRIURETIC PEPTIDE ASSAYS
#265TUBERCULOSIS ANTIGEN DETECTION ASSAYS AND VACCINES
#266Method of Diagnosis of Infection by Mycobacteria and Reagents Therefor
#267Predicting mortality and detecting severe disease
#268Biomarkers for lung disease monitoring
#269METHOD OF DIAGNOSING A RESPIRATORY DISEASE
#270LTBP2 AS A BIOMARKER FOR RENAL DYSFUNCTION
#271Compositions and methods
#272Methods and compositions for risk prediction, diagnosis, prognosis, and treatment of pulmonary disorders
#273TREATMENT OF TH17-MEDIATED AUTOIMMUNE DISEASE VIA INHIBITION OF STAT 3
#274Method to identify patients at risk for lung transplant rejection
#275Compositions and methods for treating lung disorders
#276METHOD FOR DIAGNOSING AND TREATING EMPHYSEMA
#277DIAGNOSTIC KIT FOR RESPIRATORY DISEASE
#278Use of VEGF-D in the diagnosis of lymphangioleiomyomatosis (LAM) disease
#279Cell division marker
#280Biomarkers For Prognosis of Pulmonary Diseases
#281CTGF AS A BIOMARKER, THERAPEUTIC AND DIAGNOSTIC TARGET
#282Method for detection of idiopathic interstitial pneumonia
#283RECOMBINANT 12-KDA PROTEIN USEFUL FOR THE DETECTION OF RESPIRATORY ALLERGIES
#284VACCINE COMPOSITION FOR VACCINATING DOGS AGAINST CANINE INFECTIOUS RESPIRATORY DISEASE (CIRD)
#285Diagnosis and risk stratification using NT-proET-1
#286Method for diagnosing pulmonary artery hypertension
#287Method for determining the stage of ulcerative colitis or interstitial pneumonitis and reagent kit thereof
#288Method to identify patients at risk for lung transplant rejection
#289System and method for analyzing samples labeled with 5, 10, 15, 20 tetrakis (4-carboxyphenyl) porphine (TCPP)
#290Method of screening for compounds that can be used for the treatment of respiratory conditions
#291METHODS RELATING TO BREATHING DISORDERS
#292CHARACTERIZATION OF IL-17F AND IL-17R INTERACTIONS
#293SURFACTANT PROTEINS B AND D FOR DIFFERENTIAL DIAGNOSIS OF DYSPNEA
#294DIFFERENTIATION OF CAUSES OF RIGHT HEART FAILURE
#295METHOD FOR THE DETECTION OF THE IN-VIVO ACTIVITY OF NEUROTRYPSIN, USE OF THE METHOD AND USE OF THE C-TERMINAL, 22-KDA FRAGMENT OF AGRIN AS BIOMARKER IN DIAGNOSIS AND MONITORING OF NEUROTRYPSIN-RELATED DISTURBANCES
#296COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE
#297Inhibitors of PDE4 and Methods of Use
#298Biochemical markers for acute pulmonary embolism
#299Diagnosis of conditions associated with decreased arginine bioavailability
#300FIBROSIS INHIBITOR